| Name | Title | Contact Details |
|---|
Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.
Jeffrey Moose Gallery is a Seattle, WA-based company in the Business Services sector.
Pathway Partners Wealth Advisors is a New York State registered investment advisor located in Buffalo, NY.
J & A ENGINEERING is a Marietta, GA-based company in the Business Services sector.
jingo is a Woodland Hills, CA-based company in the Business Services sector.